Adams coughs up cash for Delsym line

June 2006
Drug Store News;6/26/2006, Vol. 28 Issue 8, p14
Trade Publication
The article reports on the acquisition of Adams Respiratory Therapeutics of the Delsym cough suppressant brand from biopharmaceutical company UCB in Chester, New Jersey. The move will increase the market share of Adams in pediatric cough and cold aisles, and will secure the company's patented delivery system. The acquisition would also gain access on another drug delivery technology and create brand awareness and enhance market penetration.


Related Articles

  • UCB SELLS OTC DELSYM TO ADAMS RESPIRATORY THERAPEUTICS.  // Worldwide Biotech;Jul2006, Vol. 18 Issue 7, p3 

    Reports on the decision of UCB SA to sell Delsym, an over-the-counter drug, to Adams Respiratory Therapeutics Inc. Terms of the agreement; Use of Delsym as a cough medication in the U.S.; Background on the operations of UCB.

  • Sales speak volumes for silent switch.  // Drug Store News;4/5/2004, Vol. 26 Issue 5, p17 

    Reports on the sales performance of Mucinex, an over-the-counter (OTC) cough expectorant brand of Adams Respiratory Therapeutics, for the period ending December 28, 2003. Approval from the U.S. Food and Drug Administration for Adams Respiratory Therapeutics to market an OTC cough expectorant;...

  • UCB sells films.  // Packaging Magazine;7/29/2004, Vol. 7 Issue 14, p2 

    Reports on the decision of UCB to sell its films business to a consortium.

  • OTC.  // Drug Topics;12/11/2006, Vol. 150 Issue 23, p89 

    The article evaluates several products including Children's Mucinex MiniMelts cough granules from Adams Respiratory Therapeutics, Immune Fizz vitamins from Zipfizz Corp., and InfiAid dietary supplement from Infinity Health Sciences and offers information on its features.

  • Solutia selling UCB nonplastic operations. Esposito, Frank // Plastics News;12/9/2002, Vol. 14 Issue 41, p7 

    Reports that Saint Louis, Missouri-based Solutia Inc. sold its nylon resin and specialty films business unit to Brussels, Belgium-based UCB SA. Sale value of the unit; Utilization of the money in the payments of debts; Reasons for the sale of the unit.

  • UCB Dumps 50+ Programs in $667M Deal with GSK.  // BioWorld Today;1/26/2009, Vol. 20 Issue 15, p2 

    The article reports on the decision of UCB SA to divest its smaller business operations, reaching a deal to sell more than 50 such programs to GlaxoSmithKline PLC for 515 million euro. Included in the acquisition deal are UCB operations in the Far East, Middle East, Latin America and Africa. UCB...

  • UCB Dumps 50+ Programs in $667M Deal with GSK.  // Bioworld Week;2/2/2009, Vol. 17 Issue 5, p2 

    The article reports on the move of UCB SA to sell more its 50 programs to GlaxoSmithKline (GSK) in London, England. According to the article, the $667 million transaction covers all the market products and staff of UCB in Middle East, Latin America, Africa and Far East operations. In addition,...

  • Personal Care: Industry Update.  // MarketWatch: Global Round-up;Jul2006, Vol. 5 Issue 7, p83 

    The article reports developments related to personal care industry in the U.S. The Delaware-based, privately-held drugstore chain Happy Harry's company was acquired by America's largest drugstore chain Walgreens Co. Revlon Inc.'s share fell a record 37 percent following the firm's announcement...

  • Thomson Financial Worldwide Mergers & Acquisitions.  // Mergers & Acquisitions Report;12/17/2007, Vol. 20 Issue 48, p6 

    A list of acquisitions by companies in the U.S. is presented which includes the Adams Respiratory Therapeutics Inc., MGI Pharma Inc. and Claymont Steel Holdings Inc.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics